TD Asset Management’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
Other funds holding ABMD
TRSOTSOK
BTI
IA
AW
HNB
TD Asset Management's ABMD Position: Q4 2022 in Review
TD Asset Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 14,957 shares — an estimated $3.72M sold.
TD Asset Management first reported a position in ABMD in Q2 2018 and held it in 18 quarters. The position peaked at $14.3M in Q4 2019. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.
- TD Asset Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
- TD Asset Management sold 14,957 Abiomed Inc shares in Q4 2022, an estimated $3.72M.
- TD Asset Management first reported a position in Abiomed Inc in Q2 2018 and held it in 18 quarters.
- TD Asset Management's Abiomed Inc position peaked at $14.3M in Q4 2019.
- 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.
Based on TD Asset Management's 13F filing for Q4 2022, filed 7 Feb 2023.